Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 1 , Pages 24-29 , February 2008

Immediate respiratory management of the preterm infant

  • Sunil K. Sinha

      Affiliations

    • Paediatrics and Neonatal Medicine, University of Durham, Durham, UK
    • The James Cook University Hospital, Middlesbrough TS4 3BW, UK
    • Corresponding Author InformationCorresponding author. Paediatrics and Neonatal Medicine, University of Durham, Durham, UK.
    • ,
  • Samir Gupta

      Affiliations

    • The James Cook University Hospital, Middlesbrough TS4 3BW, UK
    • ,
  • Steven M. Donn

      Affiliations

    • Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Michigan Health System, C.S. Mott Children's Hospital, Ann Arbor, MI 48103, USA

References 

  1. Sinha SK, Donn SM. Fetal-to-neonatal maladaptation. Semin Fetal Neonatal Med. 2006;11:166–173
  2. Bhutani VK. Development of respiratory system. In:  Donn SM,  Sinha SK editor. Manual of neonatal respiratory care. Philadelphia: Mosby Elsevier; 2006;p. 3–10
  3. Donn SM, Sinha SK. Minimising ventilator induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91:F226–F230
  4. Halamek LP, Morley C. Continuous positive airway pressure during neonatal resuscitation. Clin Perinatol. 2006;33:83–98
  5. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 1999;(4):CD001456
  6. Sinha SK, Moya F, Donn SM. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?. Curr Opin Pediatr. 2007;19:150–154
  7. Moya F, Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol. 2007;34:145–177
  8. Moya F, Sinha S, Gadzinowski J, et al. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Pediatrics. 2007;119:e1361–e1370
  9. Probyn ME, Hooper SB, Dargaville PA, et al. Positive end expiratory pressure during resuscitation of premature lambs rapidly improves blood gases without adversely affecting arterial pressure. Pediatr Res. 2004;56:198–204
  10. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive airway pressure in preterm lambs. Pediatr Res. 2002;52:387–392
  11. Michna J, Jobe AH, Ikegami M. Positive end-expiratory pressure preserves surfactant function in preterm lambs. Am J Resp Crit Care Med. 1999;160:634–639
  12. Mulrooney N, Champion Z, Moss TJ, Nitsos I, Ikegami M, Jobe AH. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med. 2005;171:488–493
  13. Schlessel JS, Susskind H, Joel DD, et al. Effect of PEEP on regional ventilation and perfusion in mechanically ventilated preterm lamb. J Nucl Med. 1989;30:1342–1350
  14. Finer NN, Carlo WA, Duara S, et al. Delivery room continuous positive airway pressure/positive end expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004;114:651–657
  15. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD000143
  16. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centres. Pediatrics. 1987;79:26–30
  17. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease?. Pediatrics. 2000;105:119–201
  18. de Paoli AG, Morley C, Davis PG. Nasal CPAP for neonates: what do we know in 2003?. Arch Dis Child Fetal Neonatal Ed. 2003;88:168–172
  19. Ammari A, Suri M, Milisavljevic V, et al. Variables associated with early failure of nasal CPAP in very low birth weight infants. J Pediatr. 2005;147:341–347
  20. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331:1051–1055
  21. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999;130:e24
  22. Thomson MA. Early nasal CPAP + prophylactic surfactant for neonates at risk of RDS. The IFDAS trial. (abstract) Pediatr Res. 2001;50:304A
  23. Morley CJ, COIN trial collaborators. Nasal CPAP or ventilation for very preterm infants at birth: a randomised controlled trial – The COIN trial. E-PAS 2007;61:6090.1.
  24. Finer N. To intubate or not – that is the question: continuous positive airway pressure versus surfactant and extremely low birth weight infants. Arch Dis Child Fetal Neonatal Ed. 2006;91:F392–F394
  25. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Curr Opin Pediatr. 2007;19:155–162
  26. Finer NN, Merritt TA, Bernstein G, Job L. A multicenter, pilot study of Aerosurf™ delivered via nasal CPAP to prevent RDS in pre-term neonates. EPAS 2006;59:4840.138.

PII: S1744-165X(07)00113-8

doi: 10.1016/j.siny.2007.09.006

Seminars in Fetal & Neonatal Medicine
Volume 13, Issue 1 , Pages 24-29 , February 2008

Article Tools